Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bright Minds Biosciences (DRUG) Profit After Tax: 2020-2021

Historic Profit After Tax for Bright Minds Biosciences (DRUG) over the last 1 years, with Sep 2021 value amounting to -$11.5 million.

  • Bright Minds Biosciences' Profit After Tax fell 3895.34% to -$11.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was -$6.8 million, marking a year-over-year change of. This contributed to the annual value of -$6.8 million for FY2021, which is 2015.22% down from last year.
  • Latest data reveals that Bright Minds Biosciences reported Profit After Tax of -$11.5 million as of Q3 2021, which was down 498.91% from $2.9 million recorded in Q2 2021.
  • In the past 5 years, Bright Minds Biosciences' Profit After Tax ranged from a high of $2.9 million in Q2 2021 and a low of -$11.5 million during Q3 2021.
  • Its 2-year average for Profit After Tax is -$1.3 million, with a median of $519,340 in 2020.
  • Data for Bright Minds Biosciences' Profit After Tax shows a maximum YoY tumbled of 3,895.34% (in 2021) over the last 5 years.
  • Quarterly analysis of 2 years shows Bright Minds Biosciences' Profit After Tax stood at $519,340 in 2020, then plummeted by 3,895.34% to -$11.5 million in 2021.
  • Its Profit After Tax stands at -$11.5 million for Q3 2021, versus $2.9 million for Q2 2021 and $1.3 million for Q1 2021.